2 January 2024
Supreme plc
("Supreme", the "Company" or the "Group")
Block Admission Return
Supreme (AIM:SUP), a leading manufacturer, supplier, and brand owner of fast-moving consumer products, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements which were announced on 19 January 2023:
| Name of Company | Supreme PLC |
| Name of Scheme | Supreme 2018 EMI Scheme Supreme 2018 Unapproved Scheme Supreme 2021 CSOP Scheme Supreme 2021 Unapproved Scheme Supreme 2021 Sharesave Scheme |
| Period of Return (from/to) | 1 July 2023 to 31 December 2023 |
| Number and class of securities not issued at the start of the period under the scheme | 1,295,535 ordinary shares of £0.10 each ("Ordinary Shares"), as follows: - 617,641 Ordinary Shares under the Supreme 2018 EMI Scheme
- 193,347 Ordinary Shares under the Supreme 2018 Unapproved Scheme
- 181,026 Ordinary Shares under the Supreme 2021 CSOP Scheme
- 54,596 Ordinary Shares under the Supreme 2021 Unapproved Scheme
- 248,925 Ordinary Shares under the Supreme 2021 Sharesave Scheme
|
| Number of securities admitted during the period | 17,793 Ordinary Shares |
| Number of securities issued under the scheme during the period | 17,793 Ordinary Shares, as follows: - 17,793 Ordinary Shares under the Supreme 2018 EMI Scheme
|
| Balance under the scheme of securities not yet issued at the end of the period | 1,277,742 Ordinary Shares |
| Number and class of shares originally admitted and the date of admission | 1,989,587 Ordinary Shares on 20 January 2023 |
In compliance with the FCA's Disclosure Guidance and Transparency Rules (the "Rules"), the Company announces that, as at the date of this announcement, it has 117,338,919 Ordinary Shares in issue. The Company does not hold any Ordinary Shares in treasury and all of the Ordinary Shares have equal voting rights.
The figure of 117,338,919 Ordinary Shares represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Rules.
Enquiries:
| Supreme plc Sandy Chadha, Chief Executive Officer Suzanne Smith, Chief Finance Officer
| via Vigo Consulting |
| Shore Capital (Nominated Adviser and Joint Broker) Mark Percy / David Coaten / Rachel Goldstein - Corporate Advisory Ben Canning - Corporate Broking
| +44 (0)20 7408 4090 |
| Zeus (Joint Broker) Jordan Warburton / Alex Campbell-Harris - Investment Banking Benjamin Robertson - Corporate Broking
| +44 (0)161 831 1512 |
| Vigo Consulting (Financial Public Relations) Jeremy Garcia / Kendall Hill | +44 (0)20 7390 0230 |
About Supreme
Supreme supplies products across five categories; Batteries, Lighting, Vaping, Sports Nutrition & Wellness, and Branded Distribution. The Company's capabilities span from product development and manufacturing through to its extensive retail distribution network and direct to consumer capabilities. This vertically integrated platform provides an excellent route to market for well-known brands and products.
The Group has over 3,300 active business accounts with retail customers who manage over 10,000 branded retail outlets. Customers include B&M, Home Bargains, Poundland, Tesco, Sainsburys, Morrisons, Amazon, The Range, Costcutter, Asda, Halfords, Iceland and HM Prison & Probation Service.
In addition to distributing globally-recognised brands such as Duracell, Energizer and Panasonic, and supplying lighting products exclusively under the Energizer, Eveready, Black & Decker and JCB licences across 45 countries, Supreme has also developed brands in-house, most notably 88Vape and has a growing footprint in Sports Nutrition and Wellness via its principal brands Sci-MX and Battle Bites.
https://investors.supreme.co.uk/
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
